Baseline characteristics | n = 69 |
---|---|
Mean age of onset, mean ± SD | 55.75 ± 12.17 (range, 22–78) |
Gender | |
Male, no. (%) | 41 (59.42) |
Female, no. (%) | 28 (40.58) |
BCVA (logMAR units), total, mean ± SD | 0.64 ± 0.24 |
Sub-group of intact EZ | 0.61 ± 0.24 |
Sub-group of disrupted EZ | 0.66 ± 0.22 |
Sub-group of intact ELM | 0.60 ± 0.24 |
Sub-group of disrupted ELM | 0.68 ± 0.22 |
Central foveal thickness (μm), total, mean ± SD | 478.23 ± 172.32 |
Sub-group of intact EZ | 476.56 ± 156.02 |
Sub-group of disrupted EZ | 480.40 ± 194.21 |
Sub-group of intact ELM | 481.16 ± 181.04 |
Sub-group of disrupted ELM | 473.38 ± 160.20 |
Subfoveal choroidal thickness(μm), mean ± SD | 229.55 ± 65.07 |
Percentage of intraretinal fluid cyst, no. (%) | 45 (65.22) |
Percentage of subretinal fluid, no. (%) | 44 (63.77) |
Percentage of disrupted EZ, no. (%) | 30 (43.48) |
Percentage of disrupted ELM, no. (%) | 26 (37.68) |